STOCKHOLDERS EQUITY (DEFICIT)

12 Months Ended

Jun. 30, 2025

STOCKHOLDERS EQUITY (DEFICIT)

STOCKHOLDERS' EQUITY (DEFICIT)

NOTE 5 – STOCKHOLDERS’ EQUITY (DEFICIT)

The Company’s authorized capital consists of eighty-five million (85,000,000) shares, comprised of: (i) seventy-five million (75,000,000) shares of Common Stock, par value $0.001 per share (the “Common Stock”); and (ii) 10,000,000 shares of blank check Preferred Stock, par value $0.001 per share (the “Preferred Stock”). 

In relation to the below value of common stock issued, management estimated the fair market value of the Company’s common stock considering the thinly traded nature of its stock, the prevailing bid and ask prices, historical sales of stock, and current circumstances of the entity.  Management determined that the thinly traded price was not believed to be representative of fair value at the time of these transactions, due to the significant spread in bid and ask prices and minimal number of trades to date.  Management estimated the fair value to be $0.25 per share during the fiscal year ended June 30, 2025.

During the period from January through April 2025, as compensation to members of its Advisory Board, the Company issued a total of 32,000 shares of its common stock, having an aggregate value of $8,000 based on a share price of $0.25 per share. Services for these shares is to be rendered over a one-year period.

During the period from March through June 2025, the Company issued a total of 270,000 shares of its common stock to consultants as compensation in lieu of cash, for consulting services having an aggregate value of $67,500, based on a share price of 0.25 per share. Services for these shares is to be rendered over a one-year period.

In February 2025, the Company issued 350,000 shares of its common stock as partial compensation in the purchase of software.  The shares were valued at $87,500, based on the share price of $0.25 per share.  Also in February 2025, the Company issued 250,000 shares of its common stock to its chief executive officer pursuant to terms of a promissory note related to a zero-interest loan made to the Company (Note 7).